Company Overview and News
Lithium spot and contract price news - Spot prices slightly down, while 2018 contract prices are up.
This article was first published on Trend Investing on March 9, 2018: therefore all data is as of that date.
Lithium spot and contract price news - Lithium spot prices moved sideways, whilst 2018 global LCE contract prices are up about 20%.
Neometals Ltd (ASX:NMT) is acquiring the Mt Edwards Lithium Project near Kalgoorlie in Western Australia for a cash consideration of $2.5 million and additional contingent payments.
Welcome to the January 2017 edition of the "junior" lithium miner news. I have categorized those lithium miners that won't likely be in production much before 2020 as the juniors, rather than market cap as that fluctuates too much.
Lithium market news - Roskill has tripled their lithium demand forecast from last year, from 328ktpa to ~1mtpa by 2026.
Hannans Ltd (ASX:HNR) has been granted a trading halt by the ASX this morning, pending an update on exploration activities undertaken at the Forrestania Lithium Project.
Hannans Ltd (ASX:HNR) is commencing the second phase of lithium exploration at the Forrestania project, located circa 100 kilometres south of Southern Cross in Western Australia.
Montezuma Mining Company (ASX:MZM) has confirmed the potential for lithium mineralisation at its Lake Johnston Project in Western Australia through recently completed target generation activities.
Montezuma Mining Company (ASX:MZM) has acquired an extensive exploration database that will enable it to fast-track nickel-gold-lithium targeting at Lake Johnston located west of Norseman, Western Australia.
The drilling is planned to determine if high grade nickel is located at the base of the lava channel within the Spargos prospect. Drilling is expected to be followed by downhole geophysical surveys (DHEM) to look for ‘off-hole’ conductors that may represent massive nickel sulphide mineralisation. The Spargos prospect has all the geological characteristics of a system that one could expect to be well mineralised.
A host of downtrodden mineral exploration companies have switched their focus to lithium from out-of-favour metals, such as nickel, which have been battered by a downturn in commodity prices.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...